Cola as a quick fix for esophageal blockages in cancer patients?

NCT ID NCT06652620

Ongoing Symptom relief Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether drinking cola can help relieve sudden food blockages in the esophagus for people with esophageal cancer. Fifty participants will be randomly assigned to drink cola or receive standard care, and researchers will check if the blockage clears within 24 hours. The goal is to find a simple, non-invasive way to manage this common and distressing problem.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cola (Coca-Cola or Pepsi-Cola)
What this could lead to: If it works, this could provide a simple, at-home remedy to quickly relieve food blockages in esophageal cancer patients, avoiding emergency procedures.
What could go wrong: This is a small, early-stage trial with only 50 participants, so results may not apply to everyone. Cola might not work for all blockages, and there is a risk of aspiration or worsening symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGEAL CANCER

Contacts and locations

Locations

First People's Hospital

Jingdezhen, Jiangxi, China
Fudan University Shanghai Cancer Center

Shanghai, 200032, China
Fudan University Shanghai Cancer Center Xiamen Hospital

Xiamen, Fujian, China
The Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, 225001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.